- Home
- HCC vs ICUCW Comparison
HCC vs ICUCW Comparison
Compare HCC & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCC
- ICUCW
- Stock Information
- Founded
- HCC 2015
- ICUCW N/A
- Country
- HCC United States
- ICUCW United States
- Employees
- HCC N/A
- ICUCW 19
- Industry
- HCC Coal Mining
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- HCC Energy
- ICUCW Health Care
- Exchange
- HCC Nasdaq
- ICUCW Nasdaq
- Market Cap
- HCC 2.5B
- ICUCW N/A
- IPO Year
- HCC 2017
- ICUCW 2021
- Fundamental
- Price
- HCC $45.30
- ICUCW $0.03
- Analyst Decision
- HCC Strong Buy
- ICUCW
- Analyst Count
- HCC 5
- ICUCW 0
- Target Price
- HCC $70.25
- ICUCW N/A
- AVG Volume (30 Days)
- HCC 853.0K
- ICUCW N/A
- Earning Date
- HCC 04-30-2025
- ICUCW N/A
- Dividend Yield
- HCC 0.71%
- ICUCW N/A
- EPS Growth
- HCC N/A
- ICUCW N/A
- EPS
- HCC 2.01
- ICUCW N/A
- Revenue
- HCC $1,319,451,000.00
- ICUCW N/A
- Revenue This Year
- HCC N/A
- ICUCW N/A
- Revenue Next Year
- HCC $26.14
- ICUCW N/A
- P/E Ratio
- HCC $22.48
- ICUCW N/A
- Revenue Growth
- HCC N/A
- ICUCW N/A
- 52 Week Low
- HCC $38.00
- ICUCW N/A
- 52 Week High
- HCC $75.53
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- HCC 42.79
- ICUCW N/A
- Support Level
- HCC $43.43
- ICUCW N/A
- Resistance Level
- HCC $47.79
- ICUCW N/A
- Average True Range (ATR)
- HCC 2.00
- ICUCW 0.00
- MACD
- HCC -0.28
- ICUCW 0.00
- Stochastic Oscillator
- HCC 26.52
- ICUCW 0.00
About HCC Warrior Met Coal Inc.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.